Clinical evaluation of dried blood spots for the determination of tamoxifen and endoxifen levels

Clinical evaluation of dried blood spots for the determination of tamoxifen and endoxifen levels - Tamoxifen and endoxifen in DBS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40928

Enrollment

100

Registered

2012-11-02

Start date

2014-02-24

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer mamma carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Treated with tamoxifen - Age 18 years or older - Able and willing to give informed consent - Able and willing to undergo a fingerprick for dried blood spot sampling

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
- Ratio of the DBS and serum concentrations of tamoxifen and endoxifen	—

Secondary

Measure	Time frame
- Percentage of patients that obtains a DBS by self-sampling at home - Percentage of patients that provides DBS samples useful for analysis	—

Countries

Netherlands

Outcome results